Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 274 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 946. Clear
Clear
Q1
TAKEDA PHARMACEUTICALS AMERICA, INC. for TAKEDA PHARMACEUTICALS AMERICA INC
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Taxation/Internal Revenue Code, Trade (domestic/foreign), Defense
View →
Q1
AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) for AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Insurance, Pharmacy
View →
Q1
ALSTON & BIRD LLP for TRAVERE THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy, Medical/Disease Research/Clinical Labs
View →
Q1
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q1
AMGEN, INC. for AMGEN INC
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark
View →
Q1
PFIZER INC. for PFIZER INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q1
AVOQ, LLC for BIOTECHNOLOGY INNOVATION ORGANIZATION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $80,000.00 income
Trade (domestic/foreign), Taxation/Internal Revenue Code, Health Issues, Science/Technology
View →
Q1
NEUROCRINE BIOSCIENCES, INC for NEUROCRINE BIOSCIENCES, INC
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate
Medicare/Medicaid, Health Issues, Budget/Appropriations, Taxation/Internal Revenue Code
View →
Q1
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q1
INCYTE CORPORATION for INCYTE CORPORATION
1st Quarter (Jan 1 - Mar 31) 2025 · Delaware · House · Senate
Medicare/Medicaid
View →
Q1
BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Agriculture, Animals, Budget/Appropriations, Chemicals/Chemical Industry
View →
Q1
BIOGEN for BIOGEN
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Pharmacy, Manufacturing, Trade (domestic/foreign)
View →
1A
RARE DISEASE COMPANY COALITION for RARE DISEASE COMPANY COALITION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Pharmacy, Science/Technology
View →
Q1
SANOFI US SERVICES INC. for SANOFI US SERVICES INC
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Manufacturing, Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View →
Q1
SPLITOAK STRATEGIES LLC for ALNYLAM PHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid
View →
Q1
AVENUE SOLUTIONS for VERTEX PHARMACEUTICALS INCORPORATED
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View →
Q1
AVENUE SOLUTIONS for MERCK & CO. INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid
View →
Q1
ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
1st Quarter (Jan 1 - Mar 31) 2025 · Delaware · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code
View →
Q1
THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $50,000.00 income
Health Issues
View →
Q1
TODD STRATEGY GROUP for NOVARTIS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid
View →
Q1
JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC
1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate
Pharmacy, Science/Technology, Taxation/Internal Revenue Code, Veterans
View →
Q1
PTC THERAPEUTICS, INC. for PTC THERAPEUTICS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q1
NOVARTIS for NOVARTIS
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q1
LUNDBECK LLC for LUNDBECK LLC
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign)
View →
Q1
THE NICKLES GROUP, LLC for UCB, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Georgia · House · Senate · $60,000.00 income
Medicare/Medicaid, Taxation/Internal Revenue Code, Health Issues, Trade (domestic/foreign)
View →
Previous Page 10 of 11 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem